Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset

International Immunology

Volumn 11, Issue 8, 1999, Pages 1337-1349

  Perrin, Gaëlle ^a   Schnuriger, Valérie ^a   Quiquerez, Anne Lise ^a   Saas, Philippe ^a   Pannetier, Christophe ^b   De Tribolet, Nicolas ^a   Tiercy, Jean Marie ^a   Aubry, Jean Pierre ^c   Dietrich, Pierre Yves ^a   Walker, Paul R ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b INSERM   (France)

^c INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Brain; T lymphocytes; TCR; Tumor immunity

Indexed keywords

CD8 ANTIGEN;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BLOOD BRAIN BARRIER; BRAIN TUMOR; CELL COUNT; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOCYTE CLONE; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ASTROCYTOMA; BRAIN NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; GENES, T-CELL RECEPTOR; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0032765073     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.8.1337     Document Type: Article

References (79)

1. Boon, T., Cerottini, J. C., Van den Eynde, B., Van der Bruggen, P. and Van Pel, A. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337.
2. Pardoll, D. M. 1995. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 13:399.
3. Robbins, P. F. and Kawakami, Y. 1996. Human tumor antigens recognized by T cells. Curr. Opin. Immunol. 8:628.
4. Caignard, A., Guillard, M., Gaudin, C., Escudier, B., Triebel, F. and Dietrich, P. Y. 1996. In situ demonstration of renal cell carcinoma specific T-cell clones. Int. J. Cancer 66:564.
5. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T. and Rosenberg, S. A. 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl Acad. Sci. USA 91:6458.
6. Bakker, A. B., Schreurs, M. W., De Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J. and Figdor, C. G. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005.
7. Farace, F., Orlanducci, F., Dietrich, P. Y., Gaudin, C., Angevin, E., Courtier, M. H., Bayle, C., Hercend, T. and Triebel, F. 1994. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J. Immunol. 153:4281.
8. Mackensen, A., Carcelain, G., Viel, S., Raynal, M. C., Michalaki, H., Triebel, F., Bosq, J. and Hercend, T. 1994. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest. 93:1397.
9. Marchand, M., Van Baren, N., Weynants, P., Brichard, V., Dreno, B., Tessier, M. H., Rankin, E., Parmiani, G., Arienti, F., Humblet, Y., Bourlond, A., Vanwijck, R., Lienard, D., Beauduin, M., Dietrich, P. Y., Russo, V., Kerger, J., Masucci, G., Jager, E., De Greve, J., Atzpodien, J., Brasseur, F., Coulle, P. G., Van der Bruggen, P. and Boon, T. 1999. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer 80:219.
10. Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Restifo, N. P., Dudley, M. E., Scwarz, S. L., Spiess, P. J., Wunderlich, J. R., Parkhurst, M. R., Kawakami, Y., Seipp, C. A., Einhorn, J. H. and White, D. E. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321.
11. Nestlé, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G. and Schadendorf, D. 1998. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328.
12. Ballen, K. and Stewart, F. M. 1997. Adoptive immunotherapy. Curr. Opin. Oncol. 9:579.
13. Claret, E. J., Alyea, E. P., Orsini, E., Pickett, C. C., Collins, H., Wang, Y., Neuberg, D., Soiffer, R. J. and Ritz, J. 1997. Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. J. Clin. Invest. 100:855.
14. + T cells. J. Immunol. 160:2896.
15. Lin, X., Pease, L. R., Murray, P. D. and Rodriguez, M. 1998. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity. J. Immunol. 160:5661.
16. + immune T cells. J. Virol. 65:220.
17. + T cells. J. Gen. Virol. 77:705.
18. Hitchcock, E. R. and Morris, C. S. 1988. Mononuclear cell infiltration in central portions of human astrocytomas. J. Neurosurg. 68:432.
19. Dietrich, P.-Y., Walker, P. R., Schnuriger, V., Saas, P., Guillard, M., Gaudin, C. and Caignard, A. 1997. T cell repertoire analysis reveals significant repertoire selection during in vitro lymphocyte culture. Int. Immunol. 9:1073.
20. Miescher, S., Whiteside, T. L., de Tribolet, N. and Von Fliedner, V. 1988. In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers. J. Neurosurg. 68:438.
21. Moss, P. A., Rowland-Jones, S. L., Frodsham, P. M., McAdam, S., Giangrande, P., McMichael, A. J. and Bell, J. I. 1995. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl Acad. Sci. USA 92:5773.
22. McMichael, A. J. and O'Callaghan, C. A. 1998. A new look at T cells. J. Exp. Med. 187:1367.
23. Ward, E. S. and Qadri, A. 1997. Biophysical and structural studies of TCRs and ligands: implications for T cell signaling. Curr. Opin. Immunol. 9:97.
24. Garcia, K. C., Degano, M., Pease, L. R., Huang, M., Peterson, P. A., Teyton, L. and Wilson, I. A. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide - MHC antigen. Science 279:1166.
25. McHeyzer-Williams, M. G., Altman, J. D. and Davis, M. M. 1996. Tracking antigen-specific helper T cell responses. Curr. Opin. Immunol. 8:278.
26. Pannetier, C., Even, J. and Kourilsky, P. 1995. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16:176.
27. Levraud, J. P., Pannetier, C., Langlade-Demoyen, P., Brichard, V. and Kourilsky, P. 1996. Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the P815 murine tumor. J. Exp. Med. 183:439.
28. + T cell clones in elderly humans. J. Immunol. 158:4493.
29. + T cells. J. Immunol. 144:3980.
30. Buller, R. M., Holmes, K. L., Hugin, A., Frederickson, T. N. and Morse, H. C., III. 1987. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328:77.
31. Lin, Y., Langman, R. and Cohn, M. 1992. The priming of cytotoxic T-cell precursors is strictly helper T cell-dependent. Scand. J. Immunol. 35:621.
32. Jennings, S. R., Bonneau, R. H., Smith, P. M., Wolcott, R. M. and Chervenak, R. 1991. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell. Immunol. 133:234.
33. + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70:8301.
34. + T cells. Curr. Opin. Immunol. 10:444.
35. Ostrand-Rosenberg, S., Thakur, A. and Clements, V. 1990. Rejection of mouse sarcoma cells after transfection of MHC class II genes. J. Immunol. 144:4068.
36. - T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice. J. Immunol. 150:4900.
37. Van den Eynde, B. J. and Vander Bruggen, P. 1997. T cell defined tumor antigens. Curr. Opin. Immunol. 9:684.
38. + T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J. Exp. Med. 183:1965.
39. + T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. Blood 88:3522.
40. + T cell lineage to mount an effective tumoricidal response to syngeneic tumor-bearing novel class I MHC antigens. J. Immunol. 143:4287.
41. + T cells by B7-transfected melanoma cells. Science 259:368.
42. + cell-mediated immunity against tumors located in the 'immunologically privileged' central nervous system. Proc. Natl Acad. Sci. USA 93:10399.
43. + T cell response depending on the route of immunization. J. Immunol. 160:5522.
44. Cros, P., Allibert, P., Mandrand, B., Tiercy, J. M. and Mach, B. 1992. Oligonucleotide genotyping of HLA polymorphism on microtitre plates. Lancet 340:870.
45. Sadler, A. M., Petronzelli, F., Krausa, P., Marsh, S. G., Guttridge, M. G., Browning, M. J. and Bodmer, J. G. 1994. Low-resolution DNA typing for HLA-B using sequence-specific primers in alleleor group-specific ARMS/PCR. Tissue Antigens 44:148.
46. Genevee, C., Diu, A., Nierat, J., Caignard, A., Dietrich, P. Y., Ferradini, L., Roman-Roman, S., Triebel, F. and Hercend, T. 1992. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/v beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J. Immunol. 22:1261.
47. Pannetier, C., Delassus, S., Darche, S., Saucier, C. and Kourilsky, P. 1993. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res. 21:577.
48. Cochet, M., Pannetier, C., Regnault, A., Darche, S., Leclerc, C. and Kourilsky, P. 1992. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur. J. Immunol. 22:2639.
49. McHeyzer-Williams, M. G. and Davis, M. M. 1995. Antigen-specific development of primary and memory T cells in vivo. Science 268:106.
50. Even, J., Lim, A., Puisieux, I., Ferradini, L., Dietrich, P. Y., Toubert, A., Hercend, T., Triebel, F., Pannetier, C. and Kourilsky, P. 1995. T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. Res. Immunol. 146:65.
51. Regnault, A., Levraud, J. P., Lim, A., Six, A., Moreau, C., Cumano, A. and Kourilsky, P. 1996. The expansion and selection of T cell receptor alpha beta intestinal intraepithelial T cell clones. Eur. J. Immunol. 26:914.
52. + circulating alpha/beta T-cell repertoires are equally complex and are characterized by different levels of steady-state TCR expression. Hum. Immunol. 48:52.
53. Ebato, M., Nitta, T., Yagita, H., Sato, K. and Okumura, K. 1993. Skewed distribution of TCR V alpha 7-bearing T cells within tumor-infiltrating lymphocytes of HLA-A24(9)-positive patients with malignant glioma. Immunol. Lett. 39:53.
54. Ebato, M., Nitta, T., Yagita, H., Sato, K. and Okumura, K. 1994. Shared amino acid sequences in the NDbetaN and Nalpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma. Eur. J. Immunol. 24:2987.
55. Sensi, M. and Parmiani, G. 1995. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today 16:588.
56. Caignard, A., Dietrich, P. Y., Morand, V., Lim, A., Pannetier, C., Leridant, A. M., Hercend, T., Even, J., Kourilsky, P. and Triebel, F. 1994. Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck. Cancer Res. 54:1292.
57. Owens, T., Renno, T., Taupin, V. and Krakowski, M. 1994. Inflammatory cytokines in the brain: does the CNS shape immune responses? Immunol. Today 15:566.
58. Fabry, Z., Raine, C. S. and Hart, M. N. 1994. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today 15:218.
59. Weller, M. and Fontana, A. 1995. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain. Brain Res. Rev. 21:128.
60. Saas, P., Walker, P. R., Hahne, M., Quiquerez, A.-L., Schnuriger, V., Perrin, G., French, L., Van Meir, E. G., de Tribolet, N., Tschopp, J. and Dietrich, P. Y. 1997. Fas Ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest. 99:1173.
61. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643.
62. Casanova, J.-L. and Maryanski, J. L. 1993. Antigen-selected T-cell receptor diversity and self-nonself homology. Immunol. Today 14:391.
63. Maryanski, J. L., Jongeneel, C. V., Bucher, P., Casanova, J. L. and Walker, P. R. 1996. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CDS response is comprised of very few clones. Immunity 4:47.
64. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370:463.
65. + melanoma patients. J. Immunol. 158:5902.
66. Porcelli, S. A., Segelke, B. W., Sugita, M., Wilson, I. A. and Brenner, M. B. 1998. The CD1 family of lipid antigen-presenting molecules. Immunol. Today 19:362.
67. Cibotti, R., Cabaniols, J. P., Pannetier, C., Delarbre, C., Vergnon, I., Kanellopoulos, J. M. and Kourilsky, P. 1994. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180:861.
68. Lampson, L. A. 1995. Interpreting MHC class I expression and class I/class II reciprocity in the CNS: reconciling divergent findings. Microsc. Res. Tech. 32:267.
69. Xue, S. and Perlman, S. 1997. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus. Virology 238:68.
70. + T cell-mediated pathology. J. Immunol. 156:4050.
71. + T cell-mediated immune responses in murine Listeria monocytogenes meningoencephalitis. Eur. J. Immunol. 25:2384.
72. + T cells in autoimmune infiltrates in experimental allergic encephalomyelitis. Int. Immunol. 6:347.
73. Chaux, P., Moutet, M., Faivre, J., Martin, F. and Martin, M. 1996. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab. Invest. 74:975.
74. + T-helper and a T-killer cell. Nature 393:474.
75. Cserr, H. F. and Knopf, P. M. 1992, Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol. Today 13:507.
76. Carbone, F. R., Kurts, C., Bennett, S. R. M., Miller, J. F. A. P. and Heath, W. R. 1998. Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol. Today 19:368.
77. Heath, W. R., Kurts, C., Miller, J. F. A. P. and Carbone, F. R. 1998. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J. Exp. Med. 187:1549.
78. Arden, B., Clark, S. P., Kabelitz, D. and Mak, T. W. 1995. Human T-cell receptor variable gene segment families. Immunogenetics 42:455.
79. Chothia, C., Boswell, D. R. and Lesk, A. M. 1988. The outline structure of the T-cell alpha beta receptor. EMBO J. 7:3745.